{"lastClose": 5.949999809265137, "len": 1106, "date": "2023-03-06", "alpha_1": -0.24192015556201807, "beta_1": 1.6495601568698262, "drawup_1": 1.5486725887776869, "natr_1": 14.548767320661671, "sup_1": -0.4806722800419572, "res_1": 0.38655463958295644, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 46.798779180296386, "adx_1": 13.6762281144991, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.028329784939290698, "stratHoldAlpha_1": 250.98006427626353, "stratHoldDrawdown_1": -0.6415994330477537, "alpha_3mo": -0.19193410545862477, "beta_3mo": 1.9650408354507856, "drawup_3mo": 0.4608541290620036, "natr_3mo": 14.548767320661671, "sup_3mo": -0.09019598194825362, "res_3mo": 0.016246550410290907, "bullPattern_3mo": ["HAMMER"], "bearPattern_3mo": [], "rsi_3mo": 23.529399072734737, "adx_3mo": 37.191423919581496, "drawdown_3mo": -0.37763011608529673, "stratHoldSharpe_3mo": -2.2940811662516984, "stratHoldAlpha_3mo": 249.61587765241535, "stratHoldDrawdown_3mo": -0.33986710447676705, "Sector": "Health Care", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Market Cap": 860213569, "Country": "United States", "Name": "Allogene Therapeutics Inc.", "IPO Year": 2018.0, "alpha%_1": 0.2750143883006847, "beta%_1": 0.9067778810946424, "drawup%_1": 0.9972178004638632, "natr%_1": 0.9999986097089633, "drawdown%_1": 0.06017689800781034, "stratHoldSharpe%_1": 0.40332299491821166, "stratHoldAlpha%_1": 0.3823989261745918, "stratHoldDrawdown%_1": 0.046113129231011005, "alpha%_3mo": 0.20103045649122347, "beta%_3mo": 0.9581704454093842, "drawup%_3mo": 0.8868894449071834, "natr%_3mo": 0.999997115103916, "drawdown%_3mo": 0.0022805370635212473, "stratHoldSharpe%_3mo": 0.034802808125519544, "stratHoldAlpha%_3mo": 0.0019092206159664706, "stratHoldDrawdown%_3mo": 0.0028262780638579786}